Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis

Background. Preexposure prophylaxis (PrEP) with emtricitabine plus tenofovir disoproxil fumarate (FTC/TDF) or TDF alone reduces the risk of human immunodeficiency virus (HIV) acquisition. Understanding the risk of antiretroviral resistance selected by PrEP during breakthrough infections is important...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Infect Dis
Asıl Yazarlar: Lehman, Dara A., Baeten, Jared M., McCoy, Connor O., Weis, Julie F., Peterson, Dylan, Mbara, Gerald, Donnell, Deborah, Thomas, Katherine K., Hendrix, Craig W., Marzinke, Mark A., Frenkel, Lisa, Ndase, Patrick, Mugo, Nelly R., Celum, Connie, Overbaugh, Julie, Matsen, Frederick A., Coombs, Robert W., Lingappa, Jairam, McElrath, M. Juliana, Fife, Kenneth, Were, Edwin, Tumwesigye, Elioda, Katabira, Elly, Ronald, Allan, Bukusi, Elizabeth, Cohen, Craig, Wangisi, Jonathan, Campbell, James, Tappero, Jordan, Kiarie, James, Farquhar, Carey, John-Stewart, Grace, Mugo, Nelly Rwamba
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Major Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402339/
https://ncbi.nlm.nih.gov/pubmed/25587020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu677
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller